Prader-Willi syndrome drug market is growing at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing designations such as Fast track designation, Orphan drug designation for special drugs from regulatory bodies and development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth.
>Prader-Willi Syndrome Drug report gives information about the competitive situation among the market vendors and company profile. The market research performed over here was provided for leading growth status, including developments, segmentation, landscape analysis, product types and applications. The data and information on market size, market share and growth rate as well as industry analysis across different regions makes this report a wonderful resource for business players. This Prader-Willi Syndrome Drug market research report has gone through the proper research methodology and is validated from the professionals and analysts to ensure the eminent quality reports before presenting it to the users.
Key Market Players:
The key market players in the global Prader-Willi syndrome drug market are Pfizer Inc, Novartis AG, Novo Nordisk A/S, Soleno Therapeutics, Inc, Levo Therapeutics, Ferring B.V, Zafgen, Inc, Chong Kun Dang pharmaceutical Corp, Saniona, Millendo Therapeutics, Inc, LG Corp, Insys Therapeutics, Inc, GeneScience Pharmaceuticals Co., Ltd, Rhythm Pharmaceuticals, Inc among others.
Key Developments in the Market
In July 2019, Soleno Therapeutics, Inc is developing Diazoxide Choline novel drug which is currently phase lll of clinical trial for the treatment of Prader-Willi syndrome. Diazoxide choline is a controlled release tablet which acts as potassium channel agonist to control appetite and increases the energy expenditure of body thus, limit the progression to morbid obesity and diabetes associated with Prader-Willi syndrome
In June 2019, Levo Therapeutics, Inc is developing intranasal Carbetocin(LV-101) novel drug which is currently under phase lll of clinical trial for the treatment of Prader-Willi syndrome. Carbetocin is a synthetic analogue of oxytocin that was specially designed to increase selectivity for the oxytocin receptor versus vasopressin receptors, providing a wider therapeutic window than oxytocin which will help in controlling the hyperphagia associated with Prader-Willi syndrome
Increasing designations for special drugs from regulatory bodies is expected to drive the growth of the Prader-Willi syndrome market
Strong drug pipeline and number of clinical trials is continuously increasing for the treatment of Prader-Willi syndrome which is expected to drive the market growth
Increasing research and development initiatives and expenditure, is also expected to drive the market growth
Rising healthcare expenditures in developing countries can also act as a market driver
Low number of approved drugs for this disorder is restraining the market growth
Lack of awareness amongst people about Prader-Willi syndrome also acts as a restricting factor for this market growth
Individual’s attitude, beliefs, including inadequate communication between clinicians and patients about PWS can hinder the market growth
Inquiry For Customize Report With Discount At https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-prader-willi-syndrome-drug-market
Segmentation: Global Prader-Willi Syndrome Drug Market
Maternal Uniparental Disomy(UPD)
By Branded Drugs
Human Growth Hormone replacement
Sex hormone Replacement
By Route of Administration
By Distribution Channel
Middle East & Africa
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
Email: [email protected]